全球肌肉鬆弛药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球肌肉鬆弛药物市场需求预计将从 2023 年的 42.3 亿美元达到近 66.9 亿美元的市场规模，2024-2038 年研究期间复合年增长率为 5.22%。

肌肉鬆弛剂是一类特殊的药物，用于治疗因脱水或疲劳而引起的多种肌肉不适，如痉挛、疼痛和抽筋。这些药物不作用于中枢神经系统，而是作用于用于脑部和脊髓之间讯号传递的神经元。它们也在外科手术过程中用于放鬆肌肉。目前市面上经 FDA 核准的肌肉鬆弛药物中，巴氯芬、美他沙酮和奥芬那君很少。一般来说，肌肉鬆弛剂是非常强效的药物，会让人上瘾并可能产生副作用。用于去除脸部皱纹的药物（如肉毒桿菌）也可以归入此类药物，因为它们的用途类似于鬆弛剂。

市场动态

老年人口的成长和生活方式的改变是肌肉鬆弛药物市场的主要驱动力。全球范围内进行的外科手术数量的增加以及使用这些药物和麻醉剂来放鬆患者的肌肉可以进一步推动该市场的成长。污染率增加和紫外线照射会导致某些皮肤病，可以使用这些药物来治疗。在 COVID-19 封锁期间，肌肉鬆弛药物市场将大幅成长，因为许多人可能因缺乏体力活动而遭受肌肉不适。政府施加的严格规则、涉及的风险以及与药物相关的高成本可能会掩盖肌肉鬆弛药物市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球肌肉鬆弛药物市场的各个细分市场进行了包容性评估。肌肉鬆弛药物产业的成长和趋势为本研究提供了整体方法。

市场区隔

肌肉鬆弛药物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依药物类型

• 骨骼肌鬆弛药
• 脸部肌肉鬆弛药物
• 神经肌肉阻断剂

依给药途径

• 口服
• 可注射

按配销通路

• 医院药房
• 零售药房
• 网路药房

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肌肉鬆弛药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肌肉鬆弛药物市场的主要参与者包括 Amneal Pharmaceuticals LLC、Ipsen Biopharmaceuticals Inc.、Merz Pharmaceuticals LLC.、Par Pharmaceutical、Endo Pharmaceuticals、Vertical Pharmaceuticals、Mallinckrodt、SteriMax、Eisai Co. Ltd、Mcelceltical Pharmaceuticals、Mallinckrodt、SteriMax、Eisai Co. Ltd、Mcelceltical Pharmaceticals LLC. 。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：肌肉鬆弛药物 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按药物类型分類的市场吸引力分析
  • 按给药途径进行的市场吸引力分析
  • 按配销通路分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球肌肉鬆弛药物市场分析：依药物类型

• 按药物类型概述
• 历史和预测数据
• 依药物类型分析
• 骨骼肌鬆弛药
• 脸部肌肉鬆弛药物
• 神经肌肉阻断剂

第 6 章：全球肌肉鬆弛药物市场分析：依给药途径

• 依给药途径概述
• 历史和预测数据
• 依给药途径分析
• 口服
• 可注射

第 7 章：全球肌肉鬆弛药物市场分析：按分销管道

• 配销通路概述
• 历史和预测数据
• 按配销通路分析
• 医院药房
• 零售药房
• 网路药房

第 8 章：全球肌肉鬆弛药物市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：肌肉鬆弛药物公司的竞争格局

• 肌肉鬆弛药物市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Amneal Pharmaceuticals LLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• Ipsen Biopharmaceuticals Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merz Pharmaceuticals LLC.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Par Pharmaceutical
• 公司概况
• 公司收入
• 产品
• 最新动态
• Endo Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Vertical Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Mallinckrodt
• 公司概况
• 公司收入
• 产品
• 最新动态
• SteriMax
• 公司概况
• 公司收入
• 产品
• 最新动态
• Eisai Co. Ltd
• 公司概况
• 公司收入
• 产品
• 最新动态
• Metacel Pharmaceuticals LLC.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Teva Pharmaceuticals USA Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Muscle Relaxant Drugs Market is presumed to reach the market size of nearly USD 6.69 Billion by 2032 from USD 4.23 Billion in 2023 with a CAGR of 5.22% under the study period 2024-2038.

Muscle Relaxant Drugs are a special class of drugs used in the treatment of several discomforts caused to the muscle like spasms, pain, and cramps due to dehydration or fatigue. These drugs do not act on the central nervous system but work on the neurons used for signal transmission between the brain and the spinal cord. They are used during surgical procedures as well to relax the muscles. Few of the muscle relaxant drugs currently in the market approved by the FDA are baclofen, metaxalone, and orphenadrine. Generally, muscle relaxants are very powerful drugs which are addictive and can have side effects. Drugs used for removing wrinkles on the face like Botox can also be fit under this class of drugs since their use is like that of a relaxant.

MARKET DYNAMICS

The growing geriatric population and changing lifestyles are the main drivers of the muscle relaxant drugs market. The rise in the number of surgical procedures carried out globally and the use of these drugs along with anaesthetic to relax a patient's muscle can further propel the growth of this market. Increased rate of pollution and exposure to UV rays can cause certain skin conditions which can be treated using these drugs. The market for muscle relaxant drugs will show a great deal of growth during COVID-19 lockdown since many people can suffer from muscular discomforts due to lack of physical activity. Stringent rules imposed by governments, risks involved, and high costs associated with the drugs can obscure the growth of the muscle relaxant drugs market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Muscle Relaxant Drugs. The growth and trends of Muscle Relaxant Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Muscle Relaxant Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type

• Skeletal Muscle Relaxant Drugs
• Facial Muscle Relaxant Drugs
• Neuromuscular Blocking Agents

By Route of Administration

• Oral
• Injectable

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Muscle Relaxant Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Muscle Relaxant Drugs market include Amneal Pharmaceuticals LLC, Ipsen Biopharmaceuticals Inc., Merz Pharmaceuticals LLC., Par Pharmaceutical, Endo Pharmaceuticals, Vertical Pharmaceuticals, Mallinckrodt, SteriMax, Eisai Co. Ltd, Metacel Pharmaceuticals LLC., Teva Pharmaceuticals USA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. MUSCLE RELAXANT DRUGS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Drug Type
  • 3.7.2 Market Attractiveness Analysis By Route of Administration
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY DRUG TYPE

• 5.1. Overview By Drug Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Drug Type
• 5.4. Skeletal Muscle Relaxant Drugs Historic and Forecast Sales By Regions
• 5.5. Facial Muscle Relaxant Drugs Historic and Forecast Sales By Regions
• 5.6. Neuromuscular Blocking Agents Historic and Forecast Sales By Regions

6. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 6.1. Overview By Route of Administration
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Route of Administration
• 6.4. Oral Historic and Forecast Sales By Regions
• 6.5. Injectable Historic and Forecast Sales By Regions

7. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1. Overview By Distribution Channel
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Distribution Channel
• 7.4. Hospital Pharmacy Historic and Forecast Sales By Regions
• 7.5. Retail Pharmacy Historic and Forecast Sales By Regions
• 7.6. Online Pharmacy Historic and Forecast Sales By Regions

8. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MUSCLE RELAXANT DRUGS COMPANIES

• 9.1. Muscle Relaxant Drugs Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF MUSCLE RELAXANT DRUGS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Amneal Pharmaceuticals LLC
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Ipsen Biopharmaceuticals Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Merz Pharmaceuticals LLC.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Par Pharmaceutical
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Endo Pharmaceuticals
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Vertical Pharmaceuticals
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Mallinckrodt
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. SteriMax
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Eisai Co. Ltd
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Metacel Pharmaceuticals LLC.
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Teva Pharmaceuticals USA Inc
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Drug Type (USD MN)
• Skeletal Muscle Relaxant Drugs Market Sales By Geography (USD MN)
• Facial Muscle Relaxant Drugs Market Sales By Geography (USD MN)
• Neuromuscular Blocking Agents Market Sales By Geography (USD MN)
• Analysis By Route of Administration (USD MN)
• Oral Market Sales By Geography (USD MN)
• Injectable Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital Pharmacy Market Sales By Geography (USD MN)
• Retail Pharmacy Market Sales By Geography (USD MN)
• Online Pharmacy Market Sales By Geography (USD MN)
• Global Muscle Relaxant Drugs Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Muscle Relaxant Drugs Report
• Market Research Process
• Market Research Methodology
• Global Muscle Relaxant Drugs Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Drug Type
• Market Attractiveness Analysis By Route of Administration
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Drug Type (USD MN)
• Skeletal Muscle Relaxant Drugs Market Sales By Geography (USD MN)
• Facial Muscle Relaxant Drugs Market Sales By Geography (USD MN)
• Neuromuscular Blocking Agents Market Sales By Geography (USD MN)
• Global Market Analysis By Route of Administration (USD MN)
• Oral Market Sales By Geography (USD MN)
• Injectable Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital Pharmacy Market Sales By Geography (USD MN)
• Retail Pharmacy Market Sales By Geography (USD MN)
• Online Pharmacy Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.